LifeTech Capital

LifeTech Capital Reiterates Neutral Rating on Echo Therapeutics Following Q2 Results

UPDATE: LifeTech Capital Downgrades Echo Therapeutics Following Capital Raise

UPDATE: LifeTech Capital Reiterates Strong Speculative Buy Rating, Lowers PT on Echo Therapeutics on Clinical Progress

UPDATE: LifeTech Capital Downgrades Echo Therapeutics Following Capital Raise

UPDATE: LifeTech Capital Reiterates Strong Speculative Buy Rating, Lowers PT on Echo Therapeutics on Clinical Progress

LifeTech Capital Maintains Strong Speculative Buy on Navidea After Alseres Agreement

UPDATE: LifeTech Capital Downgrades NovaBay to Neutal, Drops PT to $1.25

LifeTech Capital Maintains Strong Speculative Buy on Navidea After Alseres Agreement

UPDATE: LifeTech Capital Downgrades NovaBay to Neutal, Drops PT to $1.25

LifeTech Capital Downgrades NovaBay Pharmaceuticals to Neutral

LifeTech Capital Maintains Strong Buy Rating and $4.75 PT on Oculus Innovative Sciences

LifeTech Capital Recent News

LifeTech Capital Maintains Bionovo Strong Speculative Buy, Lowers PT

LifeTech Capital Reiterates Buy and PT of $2.50 on NovaBay

LifeTech Capital Raises StemCells PT to $8, Maintains Strong Speculative Buy

LifeTech Capital Maintains Strong Buy on Oculus Innovative Sciences

LifeTech Capital Maintains Echo Therapeutics Strong Speculative Buy, $6 PT

LifeTech Capital Comments on Neoprobe, Maintains Strong Speculative Buy

LifeTech Capital Downgrades Marina Biotech To Neutral, $0.30 PT

LifeTech Capital Updates Echo Therapeutics With Strong Speculative Buy, $6 PT

LifeTech Capital Positive On Marina Biotech (MRNA)

LifeTech Capital On NBY Catheter Research

LifeTech Capital Maintains Strong Buy Rating, $4 PT On NBS

LifeTech Capital Comments On Merck Acquisition (MRK, ISPH)

LifeTech Capital Maintains Strong Speculative Buy on StemCells (STEM)

LifeTech Capital Maintains Bionovo Strong Speculative Buy, $7.50 PT (BNVI)

LifeTech Capital Raises Echo Therapeutics PT To $6 (ECTE)

LifeTech Capital Initiates Marina Biotech at Strong Speculative Buy (MRNA)